Midland Wealth Advisors LLC Sells 341 Shares of Danaher Co. (NYSE:DHR)

Midland Wealth Advisors LLC cut its stake in shares of Danaher Co. (NYSE:DHR) by 10.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,004 shares of the conglomerate’s stock after selling 341 shares during the period. Midland Wealth Advisors LLC’s holdings in Danaher were worth $690,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. Kentucky Retirement Systems Insurance Trust Fund boosted its holdings in Danaher by 11.6% in the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock valued at $4,874,000 after purchasing an additional 2,202 shares during the period. ORG Partners LLC boosted its stake in Danaher by 1,212.8% during the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after buying an additional 2,559 shares during the period. Generate Investment Management Ltd purchased a new position in Danaher during the fourth quarter worth about $8,044,000. Stifel Financial Corp increased its stake in Danaher by 1.3% in the 3rd quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock worth $235,583,000 after acquiring an additional 11,216 shares during the last quarter. Finally, Compass Capital Management Inc. raised its holdings in shares of Danaher by 4.8% in the 4th quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate’s stock valued at $54,615,000 after acquiring an additional 10,994 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 11.10% of the stock is currently owned by company insiders.

Danaher Stock Performance

NYSE DHR opened at $212.35 on Monday. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm has a market cap of $151.77 billion, a price-to-earnings ratio of 40.22, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The business has a 50-day moving average price of $222.51 and a 200-day moving average price of $242.62.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the business earned $2.09 earnings per share. As a group, equities research analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.32 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.60%. Danaher’s payout ratio is presently 24.24%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on DHR shares. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a research note on Friday, December 13th. Robert W. Baird cut their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Raymond James restated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Citigroup cut their price objective on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a report on Thursday, January 30th. Finally, StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.